Skip to main content
. 2014 Jun 3;9:2803–2813. doi: 10.2147/IJN.S62806

Figure 3.

Figure 3

Mean diameter of the developed NPs in 50% FBS.

Notes: (A) Change in the particle size (nm) of PS-PDLLA/DCT NPs in serum was monitored for 24 hours; (B) size distribution of developed NPs in serum at 0 and 24 hours.

Abbreviations: DCT, docetaxel; NP, nanoparticle; PS-PDLLA, poly(styrene)-b-poly(DL-lactide).